<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8VYWL4U8/dee385f7-66b9-4711-b258-bac929e29cb2/PDF"><dcterms:extent>185 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-8VYWL4U8/66b261ba-261d-4c7d-8f69-3d28b986d7f7/TEXT"><dcterms:extent>21 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-8VYWL4U8"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2014</dcterms:issued><dc:creator>Ilaš, Janez</dc:creator><dc:creator>Obreza, Aleš</dc:creator><dc:format xml:lang="sl">številka:5</dc:format><dc:format xml:lang="sl">letnik:65</dc:format><dc:format xml:lang="sl">str. 337-343</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID:3801201</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-8VYWL4U8</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="en">alpha-adrenoreceptor antagonists</dc:subject><dc:subject xml:lang="sl">antagonisti adrenergičnih receptorjev alfa</dc:subject><dc:subject xml:lang="en">benign hyperplasia of prostate</dc:subject><dc:subject xml:lang="sl">benigna hiperplazija prostate</dc:subject><dc:subject xml:lang="sl">lajšanje težav</dc:subject><dc:subject xml:lang="en">testosterone 5-alpha reductase inhibitors</dc:subject><dc:subject xml:lang="sl">zaviralci testosteron-5-alfa reduktaze</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Zdravila za zdravljenje benigne hiperplazije prostate| Drugs for treating benign hyperplasia of prostate|</dc:title><dc:description xml:lang="sl">The most important synthetic drugs used for treating benign hyperplasia of prostate are presented in the article. Active ingredients of two pharmacological groups are almost exclusively used, alpha-adrenoreceptor antagonists and testosterone-5-alpha reductase inhibitors. Briefly, some drugs, recently described in scientific and professional literature for the relief of symptoms are also mentioned</dc:description><dc:description xml:lang="sl">V prispevku je predstavljen pregled najpomembnejših sinteznih učinkovin, ki se uporabljajo za zdravljenje benigne hiperplazije prostate. Skoraj izključno se uporabljajo zdravilne učinkovine iz dveh skupin, antagonistov adrenergičnih receptorjev alfa in zaviralcev testosteron-5-alfa reduktaze. Na kratko bodo omenjene tudi nekatere druge učinkovine, ki so bile za namen lajšanja težav v zadnjem času opisane v strokovni in znanstveni literaturi</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-8VYWL4U8"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-8VYWL4U8" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-8VYWL4U8/dee385f7-66b9-4711-b258-bac929e29cb2/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-8VYWL4U8/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-8VYWL4U8" /></ore:Aggregation></rdf:RDF>